Literature DB >> 10751268

Age-related cognitive decline in hereditary spastic paraparesis linked to chromosome 2p.

P C Byrne1, P Mc Monagle, S Webb, B Fitzgerald, N A Parfrey, M Hutchinson.   

Abstract

OBJECTIVES: To investigate whether cognitive decline is part of the phenotype of SPG4-linked hereditary spastic paraparesis (HSP) and to determine whether cognitive changes are present in haplotype carriers before the onset of paraparesis.
BACKGROUND: The major locus for "pure" autosomal dominant HSP is the SPG4 locus on chromosome 2p. Cognitive impairment linked to this locus has been described in two families.
METHODS: The authors identified 19 families with "pure" autosomal dominant HSP. Five had linkage to the SPG4 locus (maximum lod score for D2S2374: 5.99 at zero recombination in four smaller families and 3.86 at zero recombination in the largest family). Haplotype construction identified a disease haplotype for all families; 41 individuals carried this haplotype (30 affected by HSP, 11 unaffected). All haplotype carriers and 41 matched controls underwent Cambridge Cognitive (CAMCOG) examination. Nonparametric significance tests were used comparing total and subset scores.
RESULTS: Haplotype carriers affected by HSP had lower total CAMCOG scores than control subjects (85.86/107 versus 96.2/107; p < 0.0005). The subsets of orientation, memory, language expression, and comprehension were also significantly lower. Ten individuals had scores < or =80/107, indicating mild dementia. Unaffected haplotype carriers had mean total CAMCOG scores lower than control subjects (91.82/107 versus 98. 09/107; p = 0.016). In both groups cognitive decline was age-dependent and scores diverged from control subjects from age 40. All SPG4-linked families showed the effect.
CONCLUSION: Mild, age-related cognitive impairment is a feature common to these families. It illustrates variable phenotypic expression at this locus and may be the first manifestation of the disease gene in individuals as yet unaffected by paraparesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751268     DOI: 10.1212/wnl.54.7.1510

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia.

Authors:  Michael A Simpson; Harold Cross; Christos Proukakis; Anna Pryde; Ruth Hershberger; Arnaud Chatonnet; Michael A Patton; Andrew H Crosby
Journal:  Am J Hum Genet       Date:  2003-10-16       Impact factor: 11.025

2.  Gray and white matter alterations in hereditary spastic paraplegia type SPG4 and clinical correlations.

Authors:  Tobias Lindig; Benjamin Bender; Till-Karsten Hauser; Sarah Mang; Daniel Schweikardt; Uwe Klose; Kathrin N Karle; Rebecca Schüle; Ludger Schöls; Tim W Rattay
Journal:  J Neurol       Date:  2015-06-09       Impact factor: 4.849

3.  Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases.

Authors:  C Depienne; C Tallaksen; J Y Lephay; B Bricka; S Poea-Guyon; B Fontaine; P Labauge; A Brice; A Durr
Journal:  J Med Genet       Date:  2005-07-31       Impact factor: 6.318

4.  Health survey of adults with hereditary spastic paraparesis compared to population study controls.

Authors:  Krister W Fjermestad; Øivind J Kanavin; Eva E Næss; Lise B Hoxmark; Grete Hummelvoll
Journal:  Orphanet J Rare Dis       Date:  2016-07-13       Impact factor: 4.123

5.  Cognitive Impairment Involving Social Cognition in SPG4 Hereditary Spastic Paraplegia.

Authors:  Ludivine Chamard; Sabrina Ferreira; Alexa Pijoff; Manon Silvestre; Eric Berger; Eloi Magnin
Journal:  Behav Neurol       Date:  2016-09-04       Impact factor: 3.342

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.